NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks

  • Raymond James cut the price target for NexImmune, Inc. NEXI from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.
  • Wells Fargo lowered the price target on Charles River Laboratories International, Inc. CRL from $325 to $300. Charles River Laboratories shares fell 0.5% to close at $231.89 on Monday.
  • Truist Securities raised Life Storage, Inc. LSI price target from $132 to $138. Life Storage shares rose 0.9% to close at $136.76 on Monday.
  • Needham raised the price target on Nerdy, Inc. NRDY from $4 to $5. Nerdy shares rose 1.1% to $3.62 in pre-market trading.
  • Mizuho raised price target for SITE Centers Corp. SITC from $15 to $17. SITE Centers shares rose 1% to $15.31 in pre-market trading.
  • HC Wainwright & Co. cut the price target on Enthusiast Gaming Holdings Inc. EGLX from $8 to $6. Enthusiast Gaming shares rose 1.6% to close at $1.96 on Monday.
  • Raymond James cut the price target for PotlatchDeltic Corporation PCH from $70 to $65. PotlatchDeltic shares fell 0.1% to close at $49.10 on Monday.
  • Wells Fargo reduced the price target on Bio-Techne Corporation TECH from $370 to $360. Bio-Techne dropped 2.1% to $370.12 in pre-market trading.
  • Truist Securities raised the price target on Extra Space Storage Inc. EXR from $200 to $225. Extra Space Storage shares fell 1.1% to $211.41 in pre-market trading.
  • Piper Sandler boosted the price target on aTyr Pharma, Inc. LIFE from $11 to $14. aTyr Pharma shares rose 2.5% to $3.73 in pre-market trading.

Don’t forget to check out our premarket coverage here .

Check out this: U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsInformation TechnologyPT ChangesSemiconductors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!